Financhill
Back

X4 Pharmaceuticals Quote, Financials, Valuation and Earnings

X4 Pharmaceuticals Price Quote

$0.60
-0.01 (-1.2%)
(Updated: December 21, 2024 at 5:54 AM ET)

X4 Pharmaceuticals Key Stats

Sell
47
X4 Pharmaceuticals (XFOR) is a Sell

Day range:
$0.57 - $0.68
52-week range:
$0.26 - $1.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.75%

Volume:
3.3M
Avg. volume:
5.3M
1-year change:
-16.13%
Market cap:
$104.4M
Revenue:
$0
EPS:
$-0.08

How Much Does X4 Pharmaceuticals Make?

Data Unavailable

Is X4 Pharmaceuticals Growing As A Company?

Data Unavailable

X4 Pharmaceuticals Stock Price Performance

What Is X4 Pharmaceuticals 52-Week High & Low?

X4 Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy X4 Pharmaceuticals?

Data Unavailable

Is X4 Pharmaceuticals Cash Flow Positive?

Data Unavailable

X4 Pharmaceuticals Return On Invested Capital

Data Unavailable

X4 Pharmaceuticals Earnings Date & Stock Price

X4 Pharmaceuticals Competitors

  • Who Are X4 Pharmaceuticals's Competitors?
    Below is a list of companies who compete with X4 Pharmaceuticals or are related in some way:
    • Grace Therapeutics Inc (GRCE)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

X4 Pharmaceuticals Dividend Yield

Data Unavailable

X4 Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -4.65%
Revenue: 0% -66.79%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.05
Upside from Last Price: 397.85%

Major Shareholders

Data Unavailable